NCT00429221 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Achenbach TM, Howell CT, Quay HC, Conners CK
National survey of problems and competencies among four- to sixteen-year-olds: parents' reports for normative and clinical samples. Monogr Soc Res Child Dev. 1991;56(3):1-131.
Dolezal C, Mellins C, Brackis-Cott E, Abrams EJ
The reliability of reports of medical adherence from children with HIV and their adult caregivers. J Pediatr Psychol. 2003 Jul-Aug;28(5):355-61.
Hollingshead, A
B. (1975). Four factor index of social status. Unpublished manuscript, Yale University, NewHa ven, CT.
Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ
The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004 Nov;23(11):1035-41.
Rizzo JA, Simons WR
Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther. 1997 Nov-Dec;19(6):1446-57; discussion 1424-5.
Swanson J, Nolan R, Pelham W (1988): Swanson, Nolan and Pelham rating scale (SNAP)
Pittsburgh, PA, Department of Psychiatry, Western Psychiatric Institute and Clinic.

ADHD Medication Adherence: A Parent-Provider Intervention Modeled From HIV

Clinical trial NCT00429221 - References